Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while 3141.T stands at 6.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-1.92%
Negative gross profit growth while 3141.T is at 5.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.60%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-4.40%
Negative operating income growth while 3141.T is at 16.77%. Joel Greenblatt would press for urgent turnaround measures.
-3.10%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-3.10%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.10%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while 3141.T stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-42.18%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-72.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
20.90%
10Y CAGR of 20.90% while 3141.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
20.90%
5Y CAGR of 20.90% while 3141.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
20.90%
3Y CAGR of 20.90% while 3141.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
89.60%
10Y net income/share CAGR of 89.60% while 3141.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
89.60%
Net income/share CAGR of 89.60% while 3141.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
89.60%
3Y net income/share CAGR of 89.60% while 3141.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09